| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MUV2
|
514.80 | 64.8B | 10.51 | 2.01 | — | — | — | 80 | 79 | 810.78 | +42.5% | 92 | 0.23 |
|
HNR1
|
251.20 | 30.3B | 12.27 | 2.52 | — | — | — | 75 | 78 | 315.98 | +17.8% | 97 | 0.34 |
|
ALV
|
438.20 | 166.6B | 15.46 | 2.66 | — | — | — | 68 | 63 | 488.18 | +7.9% | 86 | 0.46 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.